RustinNHBullHAMachinSJIsenbergASnaithMLDownPM. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. J Invest Dermatol1988; 90: 744–751.
6.
CariouRTobelemGBellucciS. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells: Inhibition of thrombomodulin dependent protein C activation. Thromb Haemost1988; 60: 54–9.
7.
FrancisRBMacgheeWGFeinsteinDI. Endothelial dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Thromb Haemost1988; 38: 412–19.
8.
KornbergABlankMKaufmanSShoenfeldY. Tissue procoagulant induction by antiphospholipid antibodies. J Immunol (in press).
9.
RoteNSWalterALydenTW. Antiphospholipid antibodies: Lobsters or red herrings?Am J Repro Immunol1992; 28: 31–9.
10.
BlankMCohenJToderVShoenfeldY. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal and anti-cardiolipin antibodies. Proc Natl Acad Sci USA1991; 88: 3069–76.
11.
BranchDWDudleyDJMitchellMD. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol1990; 163: 210–17.
12.
MendelovicSBrockeSShoenfeldY. Induction of a systemic lupus erythematosus like disease in mice by common anti-DNA idiotype. Proc Natl Acad Sci USA1988; 85: 2260–9.
13.
ShoenfeldYMozesE. Pathogenic idiotypes of antibodies and autoimmunity. FASEB J1990; 4: 2546–51.
14.
BakimerRFishmanPBlankMSredniBDjaldettiMShoenfeldY. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H3). J Clin Invest1992; 89: 1558–64.
15.
ShoenfeldY. The significance of experimental models of SLE and aPLS induced by idiotypic manipulation. Isr J Med Sci1994; 30: 10–18.
16.
BlankMKrauseIBen-BassatMShoenfeldY. Induction of experimental antiphospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmun1992; 5: 495–503.
17.
CohenJBakimerRBlankMValesiniGShoenfeldY. Pathogenic natural anticardiolipin antibodies: The experience of monoclonal gammopathy. Clin Exp Immunol (in press).
18.
BlankMTincaniAShoenfeldY. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol1994; 21: 100–4.
19.
BlankMFadenDTincaniAShoenfeldY. Immunization with anticardiolipin factor (B2GP-T) induced experimental aPLS in naive mice. J Autoimmun1994; 7: 441–445.
20.
ShoenfeldYMaroniPL. The beta-2-glycoprotein I and antiphospholipid antibodies. Clin Exp Rheumatol1992; 10: 205–8.
21.
Linker-IsraeliMDeansR. Dysregulated lymphokine production in systemic lupus erythematosus (SLE). Ann NY Acad Sci1989; 557: 567–9.
22.
HandwergerBS. T cell and B cell function in lupus. Curr Opin Rheumatol1991; 3: 757–9.
23.
RabinEMMondJJOharaJPauWE. Interferon-gamma inhibits the action of B cell stimulatory factor on resting B cells. J Immunol1986; 137: 1573–6.
24.
HooksJJMoutsopoulosHMGeisSAStahlNIDeckerJLNotkinsAL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med1979; 301: 5–8.
25.
TurnerMLondeiNFeldmannM. Human T cells from autoimmune and normal individuals can produce tumour necrosis factor. Exp J Immunol1987; 17: 1807–14.
26.
DeguchiYKishimotoS. Tumour necrosis factor/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice. Clin Exp Immun1991; 85: 392–5.
27.
Linker-IsraeliMBakkeACKitridouRCGendlerSGillisSHorwitzDA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus. J Immunol1983; 130: 2651–5.
28.
MiyasakaNNakamuraTRussellIJTalalN. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol1984; 31: 109–17.
29.
WegmannTG. The cytokine basis for cross-talk between the maternal immune and reproductive systems. Curr Opin Immunol1990; 2: 765–9.
30.
ChaouatGMenuEClarkDADyMMinkowskiMWegmannTG. Control of fetal survival in CBA×DBA/2 mice by lymphokine therapy. Reprod Fertil1990; 89: 447–58.
31.
FishmanPBakimerRBlankM. The putative role of cytokines in the induction of primary antiphospholipid syndrome in mice. Clin Exp Immunol1992; 514: 495–509.
32.
FishmanPFalach-VaknineEShoenfeldY. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin 3. J Clin Invest1993; 91: 1834–7.
33.
LalaPKGrahamCH. Mechanisms of trophoblast invasiveness and their control: The role of proteases and protease inhibitors. Cancer Metastasis Rev1990; 9: 369–79.
34.
HamiltonJAVairoGKnightKRCocksBG. Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase-type plasminogen activator activity by colony stimulating factors and other agents. Blood1991; 77: 616–27.
35.
FrancisRBMecGheeWGFeinsteinDI. Endothelial dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Thromb Haemos1988; 39: 412–14.
36.
AihanassakisIBleacklyRCPaeykauVGuilbertLBarrPJWegmannTG. The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells. J Immunol1987; 138: 37–42.
37.
BrunoECooperRJBriddellRAHoffmanR. Further examination of the effects of recombinant cytokines on the proliferation of human megakaryocytes progenitor cells. Blood1991; 77: 2339–46.
38.
DebilNHegyiENavarroS. In vitro effects of hematopoietic growth factors on the proliferation, endoreplication and maturation of human megakaryocytes. Blood1991; 77: 2326–38.
39.
LelloucheFFalconCCarrersLOMacloufJ. Selective inhibition of platelet-derived thromboxane A2 in patients with lupus anticoagulant using low dose aspirin as assessed by enzyme immunoassay. Adv Prostagland Thrombox Leuk Res1991; 21B: 611–14.
40.
SchiffEMashiachS. The use of low dose aspirin in pregnancy. Am J Reprod Immunol1992; 28: 153–6.
41.
OrdiJBarquineroJVilardellM. Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis1989; 48: 798.
42.
FramptonGCamersonJSThornMJonesSRafieryM. Successful removal of antiphospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone. Lancet1987; 2: 1023 (letter).
43.
KrauseIBlankMGuilbrudBShoenfeldY. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. Am J Reprod Immunol1993; 29: 155–61.
InbarOBlankMFadenDTincaniALorberMShoenfeldY. Prevention of fetal loss in experimental antiphospholipid syndrome by low molecular weight heparin. Am J Obstet Gynecol1993; 169: 423–6.
46.
BakimerRGuilburdBZurgilNShoenfeldY. The effect of intravenous gamma-globulin (IVGG) on the induction of experimental anti-phospholipid syndrome. Clin Immunol Immunopathol1993; 69: 97–102.
47.
ElliotGRLauwenAMPBonataIL. Prostaglandin E2 inhibits and indomethacin and aspirin enhance A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages. Br J Pharmacol1989; 96: 265–9.
